us-ftc-advocacy-filings-c540edf3255dfe69081665bc1f4a3095•FTC Staff Comment Before the Maryland State Board of Medical Examiners Concerning Proposed Regulations on Physician Dispensation of Drugs
FTC Staff Comment Before the Maryland State Board of Medical Examiners Concerning Proposed Regulations on Physician Dispensation of Drugs
us-ftc-advocacy-filings-c540edf3255dfe69081665bc1f4a3095FTC Staff Comment Before the Maryland State Board of Medical Examiners Concerning Proposed Regulations on Physician Dispensation of DrugsAdvocacy Filing
':)ct1 ; - ........ '< :::; .. " LTNTTED Si Ans OF AMU..IC A FEDERAL TRADE COMMISSION "'ASHl""CTON. D.C. JIOSao • Dece~r 31, 1986 C. Earl Bill, M.D., President Maryland State Board of Medical Examiners 201 West Preston Street Baltimore, Maryland 21201 Dear Dr. Bill: The Federal Trade Commission'f Bureaus of Competition, Consumer Protection, and Economics are pleased to respond to the request of the Maryland State Board of Medical Examiners (-Board-) for our views regarding the practice and regulation of the dispensing of prescription drugs by physicians. We un~erstand that the Board is considering regulations to impl.men~ recent legislation regarding physician dispensing (Chapter 691 of the Acts of Maryland, 1986, approved May 27, 1986, effective January 1, 1987). We believe that diapensing by physicians and other health care practitioners increases .ervice and price competition among practitioners, and between practitioners and pharmacists, to the benefit of consumers. We urge the Board to preserve and encourage such competition in any rules and regulations it may adopt concerning the dispensing of prescription drugs by physicians. Physician Dispensing The dispensing of medication by physicians is a traditional part of medical practice. Indeed, until about thirty years ago, the family physician who made house calls and dispensed medication was a familiar figure. Today, most consumers receive a prescription order from their physician and purchase the prescribed drugs from a pharmacist. Other consumers, often but not exclusively located in rural areas not served by a nearby pharmacy, atill purchas~ medication from their physician. And as competition among physicians has increased in recent years, more physicians have begun to offer their patients the convenience of dispensing prescription drugs . 1 These comments reoresent the views ot the Bureaus, and not necessarily those"of the Co~.ission. The Commission, however, has authorized submission of these comments.
,.' .. C. Earl Hill, M.D., President -2- Dispenling by physicians benefits consumers by aaximizing the number of qualified sources from ~hich they may purcnase prescription drugs, and by enabling consumers to avoid aaking a separate trip to a pharmacy. The competition resulting from dispensing by physicians may enhance the incentive for pharmacist! to offer lower prices and additional services to consumers. Opponents of physician dispensing allege that it may injur~ consumers by encouraging physicians to over-prescribe, or to limit product selection to those drugs available in the physician's office, in order to increase revenues. In our view, the physician's desire to maintain a reputation for integrity should reduce suc~ incentives. Even assuming thai such incentives exist, restraining an entire category of tranlactions by physicians is not justified. The fact that lome pharmacists may recommend the purchase of vitamins or over-the-counter medications because of their high retail margins does not ju.tifY. a restraint "n the -selling of "Soch ite1'lls by pharmaci.ts."--rhe incentive to abuse dispensing authority for economic gain appears to be no greater than the incentive to overuse any other lervices offered to patients, including, for example, follow-up vi.it., in-house laboratory testing or diagnostic imaging. If inappropriate dispensing occurs, it may be dealt with by 1e 2s restrictive means, such as peer review anc law enforcement. Opponents also argue that physician dispensing eliminates the system of ·checks anc balances" in which pharmacists review prescriptions for errors, possible allergic reactions, or potential adverse interactions ~ith other prescription or over- the-counter drugs the consumer may be using. In practice, of course, pharmacists frequently do not conduct such reviews. Moreover, to the extent that physician dispensing eliminates the opportunity for pharmacist! to act as a "check" on physician prescribing errors, this loss may be counter-balanced by a significant benefit: the elimination of medication errors that occur because of miscommunications between physicians and pharmacists, .uch as misinterpretations of written prescriptions. None of the arguments against dispensing of prescription drugs by physicians presents a compelling case for depriving consumers of the benefits of service and price competition that are likely to result. 2 For example, the Commission on Medical Discipline has the authority to discipline physicians who promote the sale of drugs or goods to a patient ·so as t~ exploit the patient for financial gain." Md. Health Occ. Code Ann. S14-S04(11) (1986) •
,.. C. Earl Bill, M.D., Pre~ident Regulation of Physician Dispensing in Marylano -3- ~ 3 Phy.ician dispensing has long been permitted by federal and .Olt Itate laws. In Maryland, physicians have not been prohibited from personally preparing and dispensing prescription drug.. The amendments recently enacted by the Maryland legi.l.ture require physicians to apply to the State Board of Medical Examiners, demonstrate to the Board's satisfaction that .uch di.pensing is in the public interest, and obtain the Board's written approval to dispense. In addition, the amendments limit dispen.ing by physicians to their own patient., require that. dispenling physicians not have a .ubstantial financial interest in a pharmacy, and require that dispen.ing phylicians meet certain labeling and record-keeping requirement ••. The amendments authorize the Board, after consulting with the State Board of Pharmacy, to adopt rules and regulations regarding the dispen.ing of prescription drugs by licensed physicians. The s~atutory requirement that a ph'ylician applying for permission to dispense meet a public interest Itandard requires the Board to determine what showing will meet thil .tandard. The legislature declined to impose restrictive conditions upon applicants. As originally introduced, Senate Bill 830 wal hostile to physician dispensing. It contained a preamble purporting to set forth as state policy that (1) dispenling by physicians and certain other health care practitioners Ihould be discouraged if adequate pharmaceutical service is available; (2) such practitioners should derive their income lolely tram the sale of their professional services; and (3) dispensing by such practitioners should be limited, absent exceptional circumstances, to starter doses. The bill would have required physicians seeking to dispense to demonstrate for the Board that there was a -need- for such dispensing, that adequate pharmaceutical services were unavailable, or that -exceptional circumstances ft warranted such dispensing. Th@ legislature considered and rejected all of those provisions and required only that the Board find that approval of a physician's application to dispense is in the pUblic interest. 3 For example, federal regulations permit physicians to dispense controlled su~stance! listed in Schedul~. II through V (21 C.F.R SS1306.02(b), 1306.ll(b), 1306.21(b), and 1 306 . 31( b ) (19 8 6) ) , sub j e c t to spec i f i c r @cord - keep in 9 requirements (21 C.F.R S130L03 (b) and (d) (1986)). Md. Health Occ. Code Ann. SI2-l02(b) (1986).
C. Earl Hill, M.D., President
We do not believe that the pUblic interest is .erved by
restrictions on phylician dispensing designed to protect-the
Iconoaic interests of specific groups or individuals. We
rlco..end Itrongly that the Board not require a demonltration of
-nled- for physician dispensing, of ·unavailability· of
ph.ra.cies, or of ·exceptional circumstances.· The public
interelt will belt be served by maxi~i%ing the number of
qualified lourcel from which consumerl may purchase prescription
drugs. A. discussed above, this will increale consumer choice
and enhance the incentive of sellers of prescription drugs to
otter lower prices and a wider range of a.rvices.
To minimize regulatory impediments to physician diapensing,
WI suggest that the Board adopt a presumption that, in-general,
physician diapensing is in the pUblic intereat. Such a
presumption Ihould operate to permit the routine and expeditious
approval of applications, except whlre the Board believ.a that
there is .vidence to rebut the presumption in the caae of •
-- p~rt.icl1lar-Physician. -Applic..an-tl -&hc.uJ..d-AO-t~ {.quir__ d ~o •• et --.---
burdensome standards of proof that might impoae unnecela.ry costs
or delays, and thus deter physicians from leeking approval.
Conclusion
The Federal Trade Commission actively encourages competition
in the health care sector to promote lower prices, higher
quality, and an increased variety of available •• rvices.
Physician dispensing increases competition among physicians, and
between physicians and pharmacists, thereby benefitting
consumers. We believe the Board would best lerve the pUblic
interest by seeking to facilitate and encourage physician
dispensing in any regulations it may adopt.
Sincerely,
Q/~Ji:L..
6!//fr(y I~ u kerma:
Director
Bureau of Competition
.. .......
Continue your research in ChatGPT or Claude
Connect Omnilex to search the legal corpus from your AI assistant.